Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 82
Titolo Data di pubblicazione Autore(i) File
Plasmacytoid dendritic cells: from heart to vessels. 1-gen-2010 Sorrentino, Rosalinda; Morello, Silvana; Pinto, Aldo
CpG-ODN increases the release of VEGF in a mouse model of lung carcinoma. 1-gen-2011 Sorrentino, Rosalinda; Morello, Silvana; Giordano, Mg; Arra, C; Maiolino, P; Adcock, Im; Pinto, Aldo
Cytotoxic activity of nemorosone in human MCF-7 breast cancer cells 1-gen-2011 Popolo, Ada; Piccinelli, ANNA LISA; Morello, Silvana; Sorrentino, Rosalinda; Osmany Cuesta, Rubio; Rastrelli, Luca; Pinto, Aldo
B Cells contribute to the Anti-tumour Activity of CpG-ODN in a Mouse Model of Metastatic Lung Carcinoma 1-gen-2011 Sorrentino, Rosalinda; Morello, Silvana; Forte, Giovanni; Montinaro, Antonella; De Vita, G; Luciano, A; Palma, G; Arra, C; Maiolino, P; Adcock, Im; Pinto, Aldo
Lung cancer and Toll-like receptors. 1-gen-2011 Pinto, Aldo; Morello, Silvana; Sorrentino, Rosalinda
NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma model. 1-gen-2011 Morello, Silvana; Sorrentino, Rosalinda; Montinaro, Antonella; Luciano, Antonio; Maiolino, Piera; Ngkelo, Anta; Arra, Claudio; Adcock Ian, M; Pinto, Aldo
Cl-IB-MECA enhances TNF-α release in peritoneal macrophages stimulated with LPS. 1-gen-2011 Forte, Giovanni; Sorrentino, Rosalinda; Montinaro, Antonella; Pinto, Aldo; Morello, Silvana
Microbiologia Molecolare e Cellulare 1-gen-2012 Maresca, Bruno; Castellano, Sabrina; Fortino, Vittorio; Morello, Silvana; Porta, Amalia
Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma 1-gen-2012 Forte, Giovanni; Sorrentino, Rosalinda; Montinaro, Antonella; Antonio, Luciano; Ian M., Adcock; Piera, Maiolino; Claudio, Arra; Carla, Cicala; Pinto, Aldo; Morello, Silvana
Adoptive Immunotherapy with Cl-IB-MECA-Treated CD8+ T Cells Reduces Melanoma Growth in Mice. 1-gen-2012 Montinaro, A; Forte, G; Sorrentino, Rosalinda; Luciano, A; Palma, G; Arra, C; Adcock, Im; Pinto, Aldo; Morello, Silvana
Polyinosinic-polycytidylic Acid limits tumor outgrowth in a mouse model of metastatic lung cancer. 1-gen-2012 Forte, G; Rega, A; Morello, Silvana; Luciano, A; Arra, C; Pinto, Aldo; Sorrentino, Rosalinda
Hyperresponsiveness to adenosine in sensitized Wistar rats over-expressing A(1) receptor. 1-gen-2012 Alfieri, A; Parisi, A; Maione, F; Grassia, G; Morello, Silvana; Ialenti, A; Mascolo, N; Cicala, C.
A general procedure to generate novel antimicrobial peptides and their use to obtain attenuated strains active as vaccine 1-gen-2013 Porta, Amalia; Morello, Silvana; Granata, Ilaria; Armenante, Annunziata; Maresca, Bruno
The adenosinergic system in cancer: Key therapeutic target 1-gen-2013 Sorrentino, Rosalinda; Pinto, Aldo; Morello, Silvana
Therapeutic potential of a pyridoxal-based vanadium(IV) complex showing selective cytotoxicity for cancer versus healthy cells 1-gen-2013 Strianese, Maria; Basile, Anna; Antonio, Mazzone; Morello, Silvana; Turco, Maria Caterina; Pellecchia, Claudio
Antiadrenergic effect of adenosine involves connexin 43 turn-over in H9c2 cells 1-gen-2013 Popolo, Ada; Morello, Silvana; Sorrentino, Rosalinda; Pinto, Aldo
Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma. 1-gen-2013 Iannone, Raffaella; Miele, Lucio; Maiolino, Piera; Pinto, Aldo; Morello, Silvana
Adenosine receptors as potential targets in melanoma 1-gen-2013 Antonella, Montinaro; Raffaella, Iannone; Pinto, Aldo; Morello, Silvana
Adenosine A(2A) receptor agonist, CGS21680, inhibits inflammation and increases FGF-2 tissue expression in carrageenin induced rat paw edema 1-gen-2014 Elisabetta, Caiazzo; Alfredo, Carmineri; Morello, Silvana; Armando, Ialenti; Carla, Cicala
Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model. 1-gen-2014 Iannone, Raffaella; Miele, Lucio; Maiolino, Piera; Pinto, Aldo; Morello, Silvana
Mostrati risultati da 21 a 40 di 82
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile